Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The following schedule applies across all Child-Pugh classes, with frequency adjusted upward for higher severity
It works with your body, amplifying existing signals rather than replacing them
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Missing 12 doses per month typically does not significantly impact overall IGF-1 trends or VAT reduction outcomes over 1216 week protocols, but frequent missed doses (more than 2 per week) reduce cumulative GH exposure enough to blunt metabolic results
You can, but continuing the supplement helps maintain the glow and protects your skin from daily pollution
The GLP-1 Factor For women using GLP-1 receptor agonists like semaglutide or tirzepatide, these concerns intensify
